Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries

Long-term use of 5α-reductase inhibitors and the risk of male breast cancer

(2014) Ruben G. Duijnhoven et al.   CANCER CAUSES & CONTROL

Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results

(2014) L. A. Brinton et al.   JNCI-Journal of the National Cancer Institute

Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride

(2013) Steven T. Bird et al.   JOURNAL OF UROLOGY

The Nordic prescription databases as a resource for pharmacoepidemiological research-a literature review

(2013) B Wettermark et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Incidence and Outcome of Male Breast Cancer: An International Population-Based Study

(2011) Hui Miao et al.   JOURNAL OF CLINICAL ONCOLOGY

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Danish Cancer Registry

(2011) Marianne Lundkjær Gjerstorff   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review

(2010) Timothy J. Wilt et al.   BJU INTERNATIONAL

Male breast cancer

(2010) César Gómez-Raposo et al.   CANCER TREATMENT REVIEWS

Male breast cancer: Risk factors, diagnosis, and management (Review)

(2010) Johansen Taber   ONCOLOGY REPORTS

The Nordic Countries as a Cohort for Pharmacoepidemiological Research

(2009) Kari Furu et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY